Market Research

Artificial Tears Market by Product Type (Cellulose-derived, Glycerin-derived, Oil-based Emulsion), Application (Contact Lens Moisture, Dry Eye Treatment), Delivery Mode - Global Forecast 2024-2030

Best Price Guarantee Length Publisher Published Date SKU
from $4,749 183 Pages 360iResearch January, 2024 IRE18418568
Best Price Guarantee
Price from $4,749
Length 183 Pages
Publisher 360iResearch
Published Date January, 2024
SKU IRE18418568

Artificial Tears Market by Product Type (Cellulose-derived, Glycerin-derived, Oil-based Emulsion), Application (Contact Lens Moisture, Dry Eye Treatment), Delivery Mode - Global Forecast 2024-2030


The Artificial Tears Market size was estimated at USD 2.06 billion in 2023 and expected to reach USD 2.23 billion in 2024, at a CAGR 8.27% to reach USD 3.60 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Artificial Tears Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Artificial Tears Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Artificial Tears Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alcon Vision LLC, Bausch & Lomb Incorporated, Bayer AG, Horus Pharma, Johnson & Johnson Services, Inc., Nicox S.A., Novartis AG, Novax Pharma, Oasis Medical, Inc., OCuSOFT Inc., OmniVision GmbH, Otsuka Pharmaceutical Co., Ltd., Prestige Consumer Healthcare Inc., Santen Pharmaceutical Co., Ltd., Scope Ophthalmics Ltd., Shire PLC by Takeda Pharmaceutical Company Limited, Similasan Corporation, Sun Pharmaceutical Industries, Inc., Taiwan Biotech Co., Ltd., Thea Pharmaceuticals Ltd., URSAPHARM Arzneimittel GmbH, Visufarma, and ZEISS Group.

Market Segmentation & Coverage

This research report categorizes the Artificial Tears Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type

Cellulose-derived
  • Glycerin-derived
  • Oil-based Emulsion
  • Polyethylene Glycol-based
  • Propylene Glycol-based
  • Sodium Hyaluronate-based
  • Application

    Contact Lens Moisture
  • Dry Eye Treatment
  • Delivery Mode

    Eye Drops
  • Ointments
  • Region

    Americas

    Argentina
  • Brazil
  • Canada
  • Mexico
  • United States

    California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific

    Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa

    Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
    The report offers valuable insights on the following aspects:

    1. Market Penetration: It presents comprehensive information on the market provided by key players.
    2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
    3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
    4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
    5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
    The report addresses key questions such as:

    1. What is the market size and forecast of the Artificial Tears Market?
    2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Artificial Tears Market?
    3. What are the technology trends and regulatory frameworks in the Artificial Tears Market?
    4. What is the market share of the leading vendors in the Artificial Tears Market?
    5. Which modes and strategic moves are suitable for entering the Artificial Tears Market?


    Note: PDF & Excel + Online Access - 1 Year


    • 1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Limitations
    1.7. Assumptions
    1.8. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    4.1. Introduction
    4.2. Artificial Tears Market, by Region
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. Rising incidences of eye disorders worldwide
    5.1.1.2. Increasing prevalence of dry eye syndrome
    5.1.1.3. Growing awareness and inclination towards early diagnosis and treatment
    5.1.2. Restraints
    5.1.2.1. Short-term effects of artificial tears
    5.1.3. Opportunities
    5.1.3.1. Introduction of improved artificial tears with enhanced stability
    5.1.3.2. Significant investments in developing innovative artificial tear formulations
    5.1.4. Challenges
    5.1.4.1. Risk pertaining to the use of contaminated artificial tears
    5.2. Market Segmentation Analysis
    5.3. Market Trend Analysis
    5.4. Cumulative Impact of High Inflation
    5.5. Porter’s Five Forces Analysis
    5.5.1. Threat of New Entrants
    5.5.2. Threat of Substitutes
    5.5.3. Bargaining Power of Customers
    5.5.4. Bargaining Power of Suppliers
    5.5.5. Industry Rivalry
    5.6. Value Chain & Critical Path Analysis
    5.7. Regulatory Framework
    6. Artificial Tears Market, by Product Type
    6.1. Introduction
    6.2. Cellulose-derived
    6.3. Glycerin-derived
    6.4. Oil-based Emulsion
    6.5. Polyethylene Glycol-based
    6.6. Propylene Glycol-based
    6.7. Sodium Hyaluronate-based
    7. Artificial Tears Market, by Application
    7.1. Introduction
    7.2. Contact Lens Moisture
    7.3. Dry Eye Treatment
    8. Artificial Tears Market, by Delivery Mode
    8.1. Introduction
    8.2. Eye Drops
    8.3. Ointments
    9. Americas Artificial Tears Market
    9.1. Introduction
    9.2. Argentina
    9.3. Brazil
    9.4. Canada
    9.5. Mexico
    9.6. United States
    10. Asia-Pacific Artificial Tears Market
    10.1. Introduction
    10.2. Australia
    10.3. China
    10.4. India
    10.5. Indonesia
    10.6. Japan
    10.7. Malaysia
    10.8. Philippines
    10.9. Singapore
    10.10. South Korea
    10.11. Taiwan
    10.12. Thailand
    10.13. Vietnam
    11. Europe, Middle East & Africa Artificial Tears Market
    11.1. Introduction
    11.2. Denmark
    11.3. Egypt
    11.4. Finland
    11.5. France
    11.6. Germany
    11.7. Israel
    11.8. Italy
    11.9. Netherlands
    11.10. Nigeria
    11.11. Norway
    11.12. Poland
    11.13. Qatar
    11.14. Russia
    11.15. Saudi Arabia
    11.16. South Africa
    11.17. Spain
    11.18. Sweden
    11.19. Switzerland
    11.20. Turkey
    11.21. United Arab Emirates
    11.22. United Kingdom
    12. Competitive Landscape
    12.1. FPNV Positioning Matrix
    12.2. Market Share Analysis, By Key Player
    12.3. Competitive Scenario Analysis, By Key Player
    13. Competitive Portfolio
    13.1. Key Company Profiles
    13.1.1. AbbVie Inc.
    13.1.2. Alcon Vision LLC
    13.1.3. Bausch & Lomb Incorporated
    13.1.4. Bayer AG
    13.1.5. Horus Pharma
    13.1.6. Johnson & Johnson Services, Inc.
    13.1.7. Nicox S.A.
    13.1.8. Novartis AG
    13.1.9. Novax Pharma
    13.1.10. Oasis Medical, Inc.
    13.1.11. OCuSOFT Inc.
    13.1.12. OmniVision GmbH
    13.1.13. Otsuka Pharmaceutical Co., Ltd.
    13.1.14. Prestige Consumer Healthcare Inc.
    13.1.15. Santen Pharmaceutical Co., Ltd.
    13.1.16. Scope Ophthalmics Ltd.
    13.1.17. Shire PLC by Takeda Pharmaceutical Company Limited
    13.1.18. Similasan Corporation
    13.1.19. Sun Pharmaceutical Industries, Inc.
    13.1.20. Taiwan Biotech Co., Ltd.
    13.1.21. Thea Pharmaceuticals Ltd.
    13.1.22. URSAPHARM Arzneimittel GmbH
    13.1.23. Visufarma
    13.1.24. ZEISS Group
    13.2. Key Product Portfolio
    14. Appendix
    14.1. Discussion Guide
    14.2. License & Pricing
    FIGURE 1. ARTIFICIAL TEARS MARKET RESEARCH PROCESS
    FIGURE 2. ARTIFICIAL TEARS MARKET SIZE, 2023 VS 2030
    FIGURE 3. ARTIFICIAL TEARS MARKET SIZE, 2018-2030 (USD MILLION)
    FIGURE 4. ARTIFICIAL TEARS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    FIGURE 5. ARTIFICIAL TEARS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 6. ARTIFICIAL TEARS MARKET DYNAMICS
    FIGURE 7. ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
    FIGURE 8. ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 9. ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
    FIGURE 10. ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 11. ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2023 VS 2030 (%)
    FIGURE 12. ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 13. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 14. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 15. UNITED STATES ARTIFICIAL TEARS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    FIGURE 16. UNITED STATES ARTIFICIAL TEARS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 17. ASIA-PACIFIC ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 18. ASIA-PACIFIC ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 21. ARTIFICIAL TEARS MARKET, FPNV POSITIONING MATRIX, 2023
    FIGURE 22. ARTIFICIAL TEARS MARKET SHARE, BY KEY PLAYER, 2023

    $4,749
    $5,749
    $6,749
    $8,749

    Research Assistance

    US: 800.298.5699
    Int'l: +1.240.747.3093
    Live help
    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Other tasks

    Cookie Settings